These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 12770951

  • 1. Serotonin upregulates the activity of phagocytosis through 5-HT1A receptors.
    Freire-Garabal M, Núñez MJ, Balboa J, López-Delgado P, Gallego R, García-Caballero T, Fernández-Roel MD, Brenlla J, Rey-Méndez M.
    Br J Pharmacol; 2003 May; 139(2):457-63. PubMed ID: 12770951
    [Abstract] [Full Text] [Related]

  • 2. Receptor-genes cross-talk: effect of chronic 5-HT(1A) agonist 8-hydroxy-2-(di-n-propylamino) tetralin treatment on the expression of key genes in brain serotonin system and on behavior.
    Popova NK, Naumenko VS, Cybko AS, Bazovkina DV.
    Neuroscience; 2010 Aug 11; 169(1):229-35. PubMed ID: 20423722
    [Abstract] [Full Text] [Related]

  • 3. Reduction of 5-hydroxytryptamine (5-HT)(1A)-mediated temperature and neuroendocrine responses and 5-HT(1A) binding sites in 5-HT transporter knockout mice.
    Li Q, Wichems C, Heils A, Van De Kar LD, Lesch KP, Murphy DL.
    J Pharmacol Exp Ther; 1999 Dec 11; 291(3):999-1007. PubMed ID: 10565817
    [Abstract] [Full Text] [Related]

  • 4. Mapping of CBV changes in 5-HT(1A) terminal fields by functional MRI in the mouse brain.
    Mueggler T, Razoux F, Russig H, Buehler A, Franklin TB, Baltes C, Mansuy IM, Rudin M.
    Eur Neuropsychopharmacol; 2011 Apr 11; 21(4):344-53. PubMed ID: 20656461
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. 5-hydroxytryptamine (5-HT)1A receptors and the tail-flick response. I. 8-hydroxy-2-(di-n-propylamino) tetralin HBr-induced spontaneous tail-flicks in the rat as an in vivo model of 5-HT1A receptor-mediated activity.
    Millan MJ, Bervoets K, Colpaert FC.
    J Pharmacol Exp Ther; 1991 Mar 11; 256(3):973-82. PubMed ID: 1826033
    [Abstract] [Full Text] [Related]

  • 11. Role of peripheral 5-HT1A receptors in detrusor over activity associated with partial bladder outlet obstruction in female rats.
    Mittra S, Malhotra S, Naruganahalli KS, Chugh A.
    Eur J Pharmacol; 2007 Apr 30; 561(1-3):189-93. PubMed ID: 17320854
    [Abstract] [Full Text] [Related]

  • 12. Involvement of 5-hydroxytryptamine1A receptors in Delta9-tetrahydrocannabinol-induced catalepsy-like immobilization in mice.
    Egashira N, Matsuda T, Koushi E, Mishima K, Iwasaki K, Shoyama Y, Fujiwara M.
    Eur J Pharmacol; 2006 Nov 21; 550(1-3):117-22. PubMed ID: 17022969
    [Abstract] [Full Text] [Related]

  • 13. 5-HT(1A) and 5-HT(7) receptors differently modulate AMPA receptor-mediated hippocampal synaptic transmission.
    Costa L, Trovato C, Musumeci SA, Catania MV, Ciranna L.
    Hippocampus; 2012 Apr 21; 22(4):790-801. PubMed ID: 21538661
    [Abstract] [Full Text] [Related]

  • 14. Mutant 5-hydroxytryptamine 1A receptor D116A is a receptor activated solely by synthetic ligands with a rich pharmacology.
    Cussac D, Palmier C, Finana F, De Vries L, Tardif S, Léger C, Bernois S, Heusler P.
    J Pharmacol Exp Ther; 2009 Oct 21; 331(1):222-33. PubMed ID: 19605522
    [Abstract] [Full Text] [Related]

  • 15. Phrenic nerve activity is enhanced by 5-HT1A receptor agonist 8-OH-DPAT in spontaneously breathing anesthetized rats.
    Valic M, Pecotic R, Dogas Z.
    J Physiol Pharmacol; 2008 Mar 21; 59(1):17-25. PubMed ID: 18441384
    [Abstract] [Full Text] [Related]

  • 16. 5-HT1A and beta-adrenergic receptors regulate proliferation of rat blood lymphocytes.
    Sempere T, Urbina M, Lima L.
    Neuroimmunomodulation; 2004 Mar 21; 11(5):307-15. PubMed ID: 15316241
    [Abstract] [Full Text] [Related]

  • 17. Mice over-expressing the 5-HT(1A) receptor in cortex and dentate gyrus display exaggerated locomotor and hypothermic response to 8-OH-DPAT.
    Bert B, Fink H, Hörtnagl H, Veh RW, Davies B, Theuring F, Kusserow H.
    Behav Brain Res; 2006 Feb 28; 167(2):328-41. PubMed ID: 16256213
    [Abstract] [Full Text] [Related]

  • 18. Co-administration of fluoxetine and WAY100635 improves short-term memory function.
    Fernández-Pérez S, Pache DM, Sewell RD.
    Eur J Pharmacol; 2005 Oct 17; 522(1-3):78-83. PubMed ID: 16214127
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Estrogen treatment blocks 8-hydroxy-2-dipropylaminotetralin- and apomorphine-induced disruptions of prepulse inhibition: involvement of dopamine D1 or D2 or serotonin 5-HT1A, 5-HT2A, or 5-HT7 receptors.
    Gogos A, Kwek P, Chavez C, van den Buuse M.
    J Pharmacol Exp Ther; 2010 Apr 17; 333(1):218-27. PubMed ID: 20042529
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.